Evidence map›Paper›PMID 42934234›Full record

ReviewSignal transduction and targeted therapy2026

The AMPK signaling pathway in cell metabolism and human diseases.

Zhengkui Zhang, Yuanzhuo Gu, HongChao He, Shilei Qiao, Yifan Shao, Xianming Long, Jun Huang, Long Zhang, Fangfang Zhou

Abstract readReview
In one paragraph

Review in Signal transduction and targeted therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhengkui Zhang *The First Affiliated Hospital of Soochow University, the Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, China.
Yuanzhuo Gu *Department of Gynecological Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China. yuanzhuo_gu@zju.edu.cn.
HongChao HeThe First Affiliated Hospital of Soochow University, the Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, China.
Shilei QiaoThe First Affiliated Hospital of Soochow University, the Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, China.
Yifan ShaoThe First Affiliated Hospital of Soochow University, the Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, China.
Xianming LongDepartment of Rheumatology and Immunology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.
Jun HuangLife Sciences Institute and State Key Laboratory of Transvascular Implantation Devices of the Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0002-7837-653X
Long ZhangLife Sciences Institute and State Key Laboratory of Transvascular Implantation Devices of the Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China. L_Zhang@zju.edu.cn.ORCID http://orcid.org/0000-0001-8139-0474
Fangfang ZhouThe First Affiliated Hospital of Soochow University, the Institutes of Biology and Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, China. zhoufangfang@suda.edu.cn.ORCID http://orcid.org/0000-0003-1870-7584

Funding

National Natural Science Foundation of China (National Science Foundation of China) 31925013Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LQN25H160030
6 · The paper itself

Abstract

Adenosine 5'-monophosphate-activated protein kinase (AMPK), a highly conserved energy-sensing kinase, plays a central role in maintaining cellular metabolic homeostasis, such as glucose/lipid metabolism, mitochondrial biogenesis, and autophagy, to counteract energetic stress. Beyond the canonical adenylate-dependent activation of AMPK by sensing the ATP:AMP/ADP ratio, emerging evidence reveals noncanonical activation mechanisms. Proper AMPK signaling is essential for physiological functions, whereas its dysregulation underlies various pathologies, including metabolic diseases, immune disorders, and cancer. This review systematically recapitulates the historical background and landmark discoveries of the AMPK field, including the discovery of AMPK, the structure of AMPK complex, upstream regulators and downstream substrates, and the transcriptional/posttranscriptional and posttranslational regulatory mechanisms. Furthermore, we delineate its roles in maintaining metabolic equilibrium, mitochondrial integrity, and immune competence across organ systems and highlight how dysregulated AMPK activity contributes to pathological diseases, encompassing alterations in its expression levels, intrinsic kinase activity, subcellular localization or upstream regulatory signaling cascades. Specifically, we focus on knock-in or knockout mouse models utilized to study AMPK-associated human diseases and the translational potential of AMPK-targeting agonists or antagonists across diverse pathological conditions. A deep understanding of the multidimensional regulatory network of AMPK and mechanistic insights with therapeutic innovations that we provide with this review will help address the challenges of complex metabolic diseases.

Indexed as

AMP-Activated Protein KinasesEnergy MetabolismMetabolic DiseasesNeoplasmsSignal TransductionAnimalsHumansMiceMitochondriaAMP-Activated Protein Kinases

Identifiers

PMID42934234
PMCPMC13710858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.